Purified CD4+ T cells from C51-CIITA vaccinated and challenged mice were also efficacious in preventing tumor growth of C51 tumor, as 50% of the animals were protected and the remaining 50% displayed a significant growth retardation. The gene discussed is CD4; the disease is neoplasm.